NHF’s QMS is ISO – 9001:2015 Certified · Government of Jamaica

An agency of the Ministry of Health & Wellness

NHF Adds New Drugs for Diabetes and Hypertension

NHF Adds New Drugs for Diabetes and HypertensionNational Health Fund and JADEP cardholders are to benefit from the addition of new drugs and drug combinations for the treatment of diabetes.

New, for the treatment of Diabetes, is Galvus Tablets with the active ingredient Vildagliptin, with a subsidy of $43 per 50mg tablet. There are also combinations of Vildagliptin and Metformin HCl with a subsidy of $42.71 per Galvus Met 50mg/500mg tablet, Galvus Met 50mg/850 mg tablet at $42.88 and Galvus Met 50mg/1000mg tablet at $40.86.

In addition, the combination of Telmisartan and Amlodipine as Twynsta, 80mg/5mg tablet and 80mg/10mg tablet, for the treatment of Hypertension, has been added with a subsidy of $74.82 and $83.67 per tablet respectively.

There is also a decrease in the subsidy for Duotrav Solution 0.0004%/0.5%, with active ingredients Travoprost and Timolol, for the treatment of Glaucoma, now at $1,591 down from $1639.02.

The changes became effective on October 28, 2013.

 

 

For further information please contact:

Rosemarie Lee or Jillian Green Tel: 906-1106

An agency of the Ministry of Health & Wellness
NHF’s QMS is ISO – 9001:2015 Certified

National Health Fund The Towers,
6th Floor 25 Dominica Drive,
Kingston 5

(876) 906-1106 / (876) 906-4381

1-888-DIAL-NHF (342-5643)

[email protected]

National Health Fund © 2024. All Rights Reserved.